These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12905663)

  • 1. [A forty-year study on hypertension].
    Liu LS; Chen MQ; Zeng GY; Zhou BF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):401-8. PubMed ID: 12905663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population].
    Wang ZW; Wu YF; Zhao LC; Li Y; Yang J; Zhou BF;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):407-11. PubMed ID: 15231166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Considerations about treatment programs of elderly patients with hypertension].
    Li H; Liu LT
    Zhong Xi Yi Jie He Xue Bao; 2009 Jul; 7(7):607-10. PubMed ID: 19615312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on therapeutic effects of zhenzhu qishi wan on stroke and hypertension of SHRsp].
    Du JR; Xing M; Lin ZR
    Zhongguo Zhong Yao Za Zhi; 2003 Jun; 28(6):557-9. PubMed ID: 15015340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hypertension in Lithuanian mariners.
    Kirkutis A; Norkiene S; Griciene P; Gricius J; Yang S; Gintautas J
    Proc West Pharmacol Soc; 2004; 47():71-5. PubMed ID: 15633617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension studies in China.
    Liu LS
    Clin Exp Hypertens A; 1989; 11(5-6):859-68. PubMed ID: 2676259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Community -based comprehensive prevention and control of hypertension in China (CCPACH Study)-prevalence and epidemiological characteristics in urban and rural area].
    Hu Y; Li L; Cao W; Zhan S; Li P; Li X; Wu T; Hu R; Zhou X; Ge R; Zhu G; Dai L; Wang Y; Wang S; Guo Y;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):177-80. PubMed ID: 11860779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease in China.
    Zhang XH; Lu ZL; Liu L
    Heart; 2008 Sep; 94(9):1126-31. PubMed ID: 18703693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accelerating epidemic of hypertension among rural Chinese women: results from Liaoning Province.
    Sun Z; Zheng L; Detrano R; Zhang D; Zhang X; Xu C; Li J; Liu S; Li J; Hu D; Sun Y
    Am J Hypertens; 2008 Jul; 21(7):784-8. PubMed ID: 18443569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and treatment of hypertensive patients with multiple concomitant cardiovascular risk factors in The Netherlands and Italy.
    Sturkenboom MC; Dieleman JP; Picelli G; Mazzaglia G; Mozaffari E; Filippi A; Cricelli C; van der Lei J
    J Hum Hypertens; 2008 Oct; 22(10):704-13. PubMed ID: 18668128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis on the effectiveness of community-based multiple risk factor interventions for hypertension prevention].
    Guo Y; Li L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):171-6. PubMed ID: 11860778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical differences in blood pressure of male youth aged 17-21 years in China.
    Lei S; Yong-Yong X; Xiao-Han D; Chang-Sheng C
    Blood Press; 2004; 13(3):169-75. PubMed ID: 15223726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, awareness, treatment, and control of hypertension in rural adults from Liaoning Province, northeast China.
    Dong G; Sun Z; Zheng L; Li J; Zhang X; Zhang X; Xu C; Li J; Hu D; Sun Y
    Hypertens Res; 2007 Oct; 30(10):951-8. PubMed ID: 18049027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.